<DOC>
	<DOCNO>NCT00000625</DOCNO>
	<brief_summary>To determine efficacy safety zidovudine ( AZT ) versus didanosine ( ddI ) , AZT plus ddI , AZT plus zalcitabine ( ddC ) prevent disease progression HIV-infected patient CD4 count 200-500 cells/mm3 .</brief_summary>
	<brief_title>A Randomized , Double-Blind Phase II/III Trial Monotherapy v . Combination Therapy With Nucleoside Analogs HIV-Infected Persons With CD4 Cells 200-500/mm3</brief_title>
	<detailed_description>Patients randomize receive AZT alone , AZT ddI , AZT ddC , ddI alone least 2 year . Patients develop AIDS whose CD4 count fall 50 percent less baseline cross another treatment arm . PER AMENDMENT 4/5/95 : Study treatment available 10/31/95 late patient still take study medication 4/30/95 , follow-up trial may complete approve .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Zalcitabine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : PCP prophylaxis , M. tuberculosis prophylaxis , short course acyclovir , chronic suppressive acyclovir , pneumovax Hib vaccine , antibiotic , rEPO GCSF grade 3 bad anemia neutropenia , systemic corticosteroid &lt; 21 day , regularly prescribed medication , vitamin herbal therapy . Patients must : HIV infection without AIDS CD4 200500 cells/mm3 . PER AMENDMENT 4/5/95 : Patients must remain ACTG 175 study treatment 4/30/95 meet toxicity management criterion continue treatment . Subjects take ACTG 175 crossover treatment eligible . Exclusion Criteria Coexisting Condition : Patients follow condition exclude : Current AIDSrelated condition minimal KS , grade 2 bad peripheral neuropathy , malignancy require systemic therapy . Concurrent Medication : Excluded : Other antiHIV drug , biologic response modifier rEPO GCSF , systemic cytotoxic chemotherapy , chronic systemic corticosteroid , drug affect AZT glucuronidation clearance . Concurrent Treatment : Excluded : Radiotherapy limit local therapy skin . Patients follow prior condition exclude : AIDSrelated condition minimal KS ; intolerance AZT , ddI , ddC study dose ; acute chronic pancreatitis . Prior Medication : Excluded : Acute therapy infection medical illness within past 14 day . Current alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Zalcitabine</keyword>
	<keyword>Didanosine</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Zidovudine</keyword>
</DOC>